Preterm Birth And PROM Testing Market Size, Share & Trends Report

Preterm Birth And PROM Testing Market Size, Share & Trends Analysis Report By Test Type (Pelvic Exam, Ultrasound, Biochemical Markers, Uterine Monitoring), By Application (PROM, Preterm Labor), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-3-68038-055-2
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the preterm birth and PROM testing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for preterm birth and PROM testing market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of preterm birth and PROM testing market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Preterm Birth And PROM Testing Market Categorization:

The preterm birth and PROM testing market was categorized into four segments, namely test type (Pelvic exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin), application (PROM, Preterm Labor, Chorioamnionitis), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The preterm birth and PROM testing market was segmented into test type, application, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The preterm birth and PROM testing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK.; France; Italy; Spain; Denmark, Sweden, Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; and Kuwait

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Preterm birth and PROM testing market companies & financials:

The preterm birth and PROM testing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • QIAGEN N.V. - QIAGEN N.V. is a multinational company that develops and markets a wide range of sample and assay technologies for applied testing, molecular diagnostics, and academic and pharmaceutical research. The company operates its business through a single operating segment by the Financial Accounting Standards Board. The company markets its products in over 130 countries through its subsidiaries. 

  • HOLOGIC, INC. - Hologic, Inc. develops, manufactures, and markets diagnostics solutions used primarily to diagnose various diseases. The company operates its business through five segments: Diagnostics, medical aesthetics, breast health, skeletal health, and GYN surgical. The company markets its products through direct sales & service personnel and a network of independent sales representatives & distributors. 

  • THE COOPER COMPANIES, INC. (COOPERSURGICAL, INC.) - Cooper Companies, Inc. is a global medical device company that provides a wide range of vision and surgical products. The company operates its business through business units-CooperVision and CooperSurgical. Through the CooperSurgical business unit, the company provides products and services, including medical devices, fertility, diagnostics, and contraception in women's health. The company has major manufacturing and distribution facilities in the U.S., the UK, the Netherlands, and Costa Rica, with other smaller locations also existing in multiple locations worldwide. 

  • ABBOTT - Abbott Laboratories is involved in discovering, developing, manufacturing, and marketing a wide range of healthcare products. The company operates its business through four reportable segments- diagnostic, established pharmaceutical, nutritional, cardiovascular, and neuromodulation products. The diagnostic products segment includes various diagnostic systems and tests. The company markets and sells its products directly to hospitals, clinics, physicians’ offices, commercial laboratories, blood banks, government agencies, and therapeutic companies through its distribution centers, public warehouses, and third-party distributors. 

  • MEDIXBIOCHEMICA - Medix Biochemica Group manufactures and supplies rapid tests for human healthcare. The company also provides raw materials, such as antigens, antibodies, and biological, to IVD manufacturers. Through its Actim business unit, the company develops, manufactures, and markets innovative point-of-care diagnostic rapid tests that provide results for infectious and gastrointestinal diseases within minutes. The company has affiliates in the U.S., Finland, and China and markets its products in over 70 countries. 

  • SERA PROGNOSTICS - Sera Prognostics is an American diagnostics company involved in developing and commercializing diagnostic tests intended for the early prediction of premature birth, preeclampsia, and other pregnancy complications. The company applies its advanced proprietary mass spectrometry and bioinformatics platform technologies to detect biologically significant protein expression differences to build high-performing predictions of pregnancy complications (including preterm birth, gestational diabetes, preeclampsia, growth restriction, and others). The company also has a robust pipeline of novel, innovative tests focused on other pregnancy complications. 

  • CLINICAL INNOVATIONS, LLC - Clinical Innovations, LLC is a medical devices manufacturer exclusively focused on labor & delivery and Neonatal Intensive Care Unit (NICU). The company develops, manufactures, and markets medical devices, including rupture of membrane tests, catheters, and vacuum delivery systems. In February 2020, LABORIE Medical Technologies acquired Clinical Innovations. Following the acquisition, the company was formed as a new business unit focused on medical device solutions in gynecology, obstetrics, and neonatal health. 

  • BIOSYNEX - Biosynex is a French diagnostics company involved in developing, manufacturing, and marketing innovative rapid diagnostic tests for diagnosis and prevention of a wide range of diseases. The company offers self-tests for self-monitoring and professional tests used by health professionals. It markets its rapid diagnostic tests in France and more than 70 countries through various distribution networks (offices, laboratories, hospitals, etc.).

  • NX PRENATAL, INC. - NX Prenatal, Inc. is a private molecular diagnostics company involved in developing innovative diagnostic assays for adverse pregnancy conditions such as preterm birth. The company deploys its proprietary NeXosome platform, which allows innovative isolation and enrichment of microvesicle and exosome particles from bodily fluids for noninvasive biomarker assessment. 

  • IQ PRODUCTS - IQ Products is a private medical devices company involved in developing, manufacturing, and marketing a wide range of antibody-based diagnostic solutions. The company was established with the leading University of Groningen, north of The Netherlands. Currently, the company is involved in extensive R&D activities in pregnancy-related disorders. The company supplies its products directly to end users in the Netherlands, mainly general and academic hospitals. The company provides its products in a limited number of other countries through its network of distributors.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Preterm Birth And PROM Testing Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Preterm Birth And PROM Testing Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon